- Home
- TAK vs SYY Comparison
TAK vs SYY Comparison
Compare TAK & SYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- SYY
- Stock Information
- Founded
- TAK 1781
- SYY 1969
- Country
- TAK Japan
- SYY United States
- Employees
- TAK N/A
- SYY N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- SYY Food Distributors
- Sector
- TAK Health Care
- SYY Consumer Discretionary
- Exchange
- TAK Nasdaq
- SYY Nasdaq
- Market Cap
- TAK 43.3B
- SYY 36.3B
- IPO Year
- TAK N/A
- SYY N/A
- Fundamental
- Price
- TAK $14.52
- SYY $76.41
- Analyst Decision
- TAK
- SYY Buy
- Analyst Count
- TAK 0
- SYY 12
- Target Price
- TAK N/A
- SYY $86.25
- AVG Volume (30 Days)
- TAK 3.3M
- SYY 3.3M
- Earning Date
- TAK 10-30-2025
- SYY 10-28-2025
- Dividend Yield
- TAK 1.90%
- SYY 2.85%
- EPS Growth
- TAK N/A
- SYY N/A
- EPS
- TAK 0.14
- SYY 3.73
- Revenue
- TAK $29,846,840,032.00
- SYY $82,034,000,000.00
- Revenue This Year
- TAK $0.01
- SYY $4.82
- Revenue Next Year
- TAK $0.49
- SYY $4.85
- P/E Ratio
- TAK $104.21
- SYY $20.36
- Revenue Growth
- TAK N/A
- SYY 2.92
- 52 Week Low
- TAK $12.80
- SYY $67.12
- 52 Week High
- TAK $15.69
- SYY $83.47
- Technical
- Relative Strength Index (RSI)
- TAK 62.71
- SYY 51.59
- Support Level
- TAK $14.01
- SYY $74.20
- Resistance Level
- TAK $14.56
- SYY $77.46
- Average True Range (ATR)
- TAK 0.17
- SYY 1.30
- MACD
- TAK 0.08
- SYY 0.35
- Stochastic Oscillator
- TAK 95.50
- SYY 76.23
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About SYY Sysco Corporation
Sysco is the largest US foodservice distributor with 17% share of the highly fragmented $370 billion domestic market. It distributes roughly 500,000 food and nonfood products to restaurants (60% of fiscal 2025 revenue), education and government buildings (8%), healthcare facilities (8%), travel and leisure (7%), and other locations (17%) where individuals consume away-from-home meals. In fiscal 2025, 70% of the firm's revenue was derived from its US foodservice operations, while its international (18%), quick-service logistics (10%), and other (2%) segments contributed the rest.